Fesarius Therapeutics
Fesarius Therapeutics is a Healthcare & Life Sciences startup based in New York, the United States, most recent round Series A, 1 tracked investor.
About Fesarius Therapeutics
Fesarius Therapeutics is a company headquartered in New York, the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Fesarius Therapeutics develops patented differential density hydrogel dermal matrices, including the FDA-cleared DermiSphere, to support tissue integration, vascularization, and new tissue formation for applications in wound care, reconstructive surgery, and regenerative medicine.
Explore Fesarius Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.